Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 12, 2020
[Challenges of Determining the Prevalence and Incidence of Urothelial Carcinoma in Early Benefit Assessment]Joelin Wortmann, Daniel Wirth
Biophysical Journal|May 7, 2021
Neural network strategies for plasma membrane selection in fluorescence microscopy imagesDaniel Wirth, Alec McCall, Kalina Hristova
Biochimica Et Biophysica Acta. Biomembranes|June 17, 2024
Probing phosphorylation events in biological membranes: The transducer functionDaniel Wirth, Ece Özdemir, Kalina Hristova
Nature Communications|November 21, 2023
Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand bindingDaniel Wirth, Ece Özdemir, Kalina Hristova
BMC Health Services Research|March 9, 2017
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in GermanyDaniel Wirth, Ramesh Dass, Robert Hettle
Biochimica Et Biophysica Acta. Biomembranes|April 10, 2018
Interactions between NRP1 and VEGFR2 molecules in the plasma membraneChristopher King, Daniel Wirth, Samuel Workman, et al.
Biochimica Et Biophysica Acta. General Subjects|August 30, 2017
Cooperative interactions between VEGFR2 extracellular Ig-like subdomains ensure VEGFR2 dimerizationChristopher King, Daniel Wirth, Samuel Workman, et al.
BMC Gastroenterology|November 11, 2019
Indirect costs associated with ulcerative colitis: a systematic literature review of real-world dataJoelle Constantin, Petar Atanasov, Daniel Wirth, et al.
Chemsystemschem|November 7, 2022
Direct quantification of ligand-induced lipid and protein microdomains with distinctive signaling propertiesDaniel Wirth, Michael D Paul, Elena B Pasquale, et al.
European Journal of Clinical Pharmacology|December 17, 2015
First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in GermanyKathrin Kuhr, Daniel Wirth, Kunal Srivastava, et al.
Pageof 3